Pay attention to the potential risks of anti-vascular endothelial growth factor therapy for neovascular disease / 中华眼底病杂志
Chinese Journal of Ocular Fundus Diseases
; (6): 2-5, 2010.
Article
em Zh
| WPRIM
| ID: wpr-380024
Biblioteca responsável:
WPRO
ABSTRACT
Anti-vascular dndothelial growth factor (VEGF) drugs have open up a new treatment channel for ocular neovascular diseases.A lots of clinical data has proved that anti VEGF drugs are effective and safe.But we should also notice that long-term and excessive usage of anti-VEGF drugs brings some new problems and complications,and even affect the normal ocular physiological process of the angiogenesis and retinal blood flow.So,it is necessary to pay attention to the problems and potential risks of excessive usage of anti VEGF therapies for ocular neovascular disease.
Texto completo:
1
Base de dados:
WPRIM
Tipo de estudo:
Etiology_studies
Idioma:
Zh
Revista:
Chinese Journal of Ocular Fundus Diseases
Ano de publicação:
2010
Tipo de documento:
Article